They showed that treatment with either DNA methyltransferase (DNMT) or histone deacetylase (HDAC) inhibitors could increase ICAM-1 expression on tumour ECs and thus potentiate leucocyte infiltration in two different mouse tumour models [135]. This evidence concerns the gene HDAC9 and neoplasm.